ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Ji-li Xu

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-1505-041X; OpenAlex author ID A5003009533.

Their work

Papers: 2 (first author 2, last author 0)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic Cancer. First author DOI 10.1007/s10620-022-07620-7 ↗
A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target. First author DOI 10.1007/s10637-021-01176-5 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Yong Guo · 1 shared paper, 2022
- Paper A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic … DOI 10.1007/s10637-021-01176-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.